• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits

    6/2/25 9:41:15 AM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email
    false 0002014596 0002014596 2025-06-01 2025-06-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of Earliest Event Reported): June 1, 2025

     

     

     

    CONCENTRA GROUP HOLDINGS PARENT, INC.

    (Exact Name of Registrant as Specified in Its Charter)

     

     

     

    001-42188

    (Commission File Number)

     

    Delaware 30-1006613
    (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.)

     

    5080 Spectrum Drive, Suite 1200W

    Addison, TX, 75001

    (Address of principal executive offices) (Zip code)

     

    (972) 364-8000

    (Registrant’s telephone number, including area code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class  

    Trading

    Symbol(s)

      Name of each exchange on which registered
    Common Stock, $0.01 par value per share   CON   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 2.01Completion of Acquisition or Disposition of Assets

     

    Effective June 1, 2025, Concentra Health Services, Inc. (“CHS”), a wholly owned subsidiary of Concentra Group Holdings Parent, Inc. (the “Company”), consummated the previously announced acquisition of Onsite Innovations, LLC (“Onsite Innovations”), pursuant to the terms of an equity purchase agreement, dated April 18, 2025 (the “Purchase Agreement”), by and between CHS and Pivot Occupational Health, LLC (the “Seller”). Pursuant to the terms of the Purchase Agreement, CHS acquired all of the outstanding equity interests of Onsite Innovations from the Seller and paid a purchase price of $55 million, subject to certain customary adjustments in accordance with the terms set forth in the Purchase Agreement. CHS financed the transaction using a combination of cash on hand and available borrowing capacity under its existing revolving credit facility. Onsite Innovations operates approximately 200 onsite health clinics at employer locations in over 40 states, providing occupational health, wellness, prevention, and performance services.

     

    Item 7.01Regulation FD Disclosure.

     

    On June 2, 2025, the Company issued a press release announcing the consummation of the previously announced acquisition of all of the issued and outstanding equity interests of Onsite Innovations by CHS pursuant to the terms of the Purchase Agreement (the “Press Release”). A copy of the Press Release is attached as Exhibit 99.1 to this report and incorporated herein by reference.

     

    The information in this Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

     

    Item 9.01Financial Statements and Exhibits.

     

    (d) Exhibits.

     

    Exhibit Number Description
       
    99.1 Press Release, dated June 2, 2025, issued by Concentra Group Holdings Parent, Inc.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

      CONCENTRA GROUP HOLDINGS PARENT, INC.
       
    Date: June 2, 2025 By: /s/ Timothy Ryan
        Timothy Ryan
        Executive Vice President and Chief Legal Counsel

     

     

     

    Get the next $CON alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    8/19/2024$29.00Overweight
    JP Morgan
    8/19/2024$32.00Buy
    Goldman
    8/19/2024$28.00Outperform
    Mizuho
    More analyst ratings

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentra Expands to Union City, Georgia

    Concentra®, (NYSE:CON) the nation's leader in occupational medicine, today announced the opening of a new medical center in Union City, Georgia. The medical center, Concentra Union City, is conveniently located at 6851 Shannon Parkway, Suite 5, Union City, Georgia 30291. "Concentra Union City marks our continued expansion in the Atlanta area," said Janet Cobb, MD, senior vice president of Concentra medical operations. "We look forward to serving Atlanta employers at our new medical center." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location in Union City. Telem

    8/11/25 8:00:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2025, Cash Dividend, and Raised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. "Concentra delivered strong results in the second quarter, building on our solid start to 2025," said Keith Newton, Chief Executive Officer of Concentra. "Our results reflected strength across several key measures, including growth in patient visits, rate, revenue, and Adjusted EBITDA. We are well-positioned for continued momentum driven by the disciplined execution of our strategy by our outs

    8/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra® to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 8, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Gopal Vipin

    3 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    7/2/25 8:52:23 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form 3 filed by new insider Bonner Brigid A.

    3 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    7/1/25 7:03:18 PM ET
    $CON
    Medical Specialities
    Health Care

    Director Ortenzio Robert A disposed of 3,070,367 shares and acquired 1,023,455 shares (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    3/4/25 4:59:26 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    SEC Filings

    View All

    SEC Form 10-Q filed by Concentra Group Holdings Parent Inc.

    10-Q - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    8/7/25 5:09:49 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    8/7/25 4:42:38 PM ET
    $CON
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Concentra Group Holdings Parent Inc.

    SCHEDULE 13G/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    7/7/25 1:20:33 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Concentra Group Holdings Parent upgraded by BofA Securities with a new price target

    BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00

    12/16/24 6:50:31 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent downgraded by BofA Securities with a new price target

    BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously

    10/7/24 7:46:54 AM ET
    $CON
    Medical Specialities
    Health Care

    RBC Capital Mkts initiated coverage on Concentra Group Holdings Parent with a new price target

    RBC Capital Mkts initiated coverage of Concentra Group Holdings Parent with a rating of Outperform and set a new price target of $33.00

    8/20/24 6:52:13 AM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    View All

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/9/24 6:02:26 AM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/6/24 4:32:57 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

    SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/3/24 4:21:17 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Financials

    Live finance-specific insights

    View All

    Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2025, Cash Dividend, and Raised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. "Concentra delivered strong results in the second quarter, building on our solid start to 2025," said Keith Newton, Chief Executive Officer of Concentra. "Our results reflected strength across several key measures, including growth in patient visits, rate, revenue, and Adjusted EBITDA. We are well-positioned for continued momentum driven by the disciplined execution of our strategy by our outs

    8/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra® to Announce Second Quarter 2025 Results on Thursday, August 7, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its second quarter ended June 30, 2025, on Thursday, August 7, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, August 8, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's website at https://ir.concentra.com. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    7/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results For Its First Quarter Ended March 31, 2025, Cash Dividend, and Revised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its first quarter ended March 31, 2025, and the declaration of a cash dividend. "Concentra reported a solid start to 2025 with strong revenue and Adjusted EBITDA growth in the first quarter. With a deep understanding of patient and client needs and market dynamics, we continue to execute on key drivers of growth and deliver a comparative market advantage. Maintaining this focus ensures we continue to achieve our strategic business objectives for the year," said Keith Newton, Chief Executive Officer of

    5/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care